Cited by 119Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and ManagementEndometrial and Cervical Cancer Treatments

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis

Open access

Shaw, Robert W.·1992·Fertility and Sterility

DOI 10.1016/s0015-0282(16)55205-4

Open this paper in CoChat — free account

Abstract

Objective To compare the efficacy and safety of goserelin depot and danazol for endometriosis. Design Open, randomized comparative trial. Setting Multicenter European academic clinical institutions. Patients A total of 307 patients with laparoscopically diagnosed endometriosis were randomized to goserelin (n = 204) or danazol (n = 103); 249 patients underwent second look laparoscopy (175 received goserelin and 74 danazol) and were analyzed for efficacy. Interventions A 3.6-mg depot of goserelin monthly subcutaneously or oral danazol 200 mg three times a day administered for 24 weeks. Main outcome measures Efficacy assessments were based on changes in visible deposits at laparoscopy before and after treatment and subjective symptom scores at 4-week intervals during treatment and 8-week intervals after treatment for up to 24 weeks. Safety was assessed by adverse event reporting and clinical laboratory measures. Results There were similar proportions of symptomatic (73%) and asymptomatic (but infertile) (27%) and comparable distribution of different severity of endometriosis randomized to each treatment. Significantly fewer patients randomized to goserelin (6.4%) withdrew during treatment compared with 20.4% randomized to danazol (P less than 0.05). There were significantly reduced visible deposits of endometriosis found post-treatment (P less than 0.0001) within each group but no differences between the treatments. The mean total subjective symptoms scores remained significantly less than entry at 24 weeks post-treatment (P less than 0.05). Hypoestrogenic side effects were more common in those receiving goserelin, particularly hot flushes, but anabolic/androgenic side effects of weight gain and muscle cramps were more common in those receiving danazol. Conclusions The monthly administered 3.6-mg depot preparation of goserelin was highly effective at inducing resolution of endometriotic implants and relieving the symptoms of endometriosis with prevention of their return during 24 weeks follow-up in the majority of patients. However, results were not significantly different from those achieved with danazol 600 mg/d.

Integrity signals

Registry

Crossref · 10.1016/s0015-0282(16)55205-4

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Revised American Fertility Society Classification of Endometriosis: 1985
(1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48430-x · Cited by 1,803
Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma
DUNN, J. F., NISULA, B. C., & RODBARD, D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-58 · Cited by 1,238
Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis
Henzl, M. R., Corson, S. L., Moghissi, K. S., Buttram, V. C., Berqvist, C., & Jacobson, J. B. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802253180805 · Cited by 359
“MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.
Meldrum, D. R., Chang, R. J., LU, J., Vale, W., Rivier, J., & Judd, H. L. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-5-1081 · Cited by 248
Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis
Lemay, A., Maheux, R., Faure, N., Jean, C., & Fazekas, A. T. A. (1984) · Fertility and Sterility · doi:10.1016/s0015-0282(16)47899-4 · Cited by 209
Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up
Barbieri, R. L., Evans, S., & Kistner, R. W. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)46331-4 · Cited by 172
CLINICAL APPLICATIONS OF LHRH AND ITS ANALOGUES
Sandow, J. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00595.x · Cited by 145
Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist.
Steingold, K. A., Cedars, M. I., Lu, J. K. H., Randle, D., Judd, H. L., & Meldrum, D. R. (1987) · PubMed · Cited by 131
Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin)
Schriock, E. D., Monroe, S. E., Henzl, M. R., & Jaffe, R. B. (1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48970-3 · Cited by 110
Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.
Shaw, R. W., Fraser, H. M., & Boyle, H. (1983) · BMJ · doi:10.1136/bmj.287.6406.1667 · Cited by 102
Self-citation

Show all 18 references

Sorted by citations

Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications
Stratton, P., & Berkley, K. J. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq050 · Cited by 442
Treatment of Endometriosis
Olive, D. L., & Pritts, E. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450407 · Cited by 340
Reevaluating response and failure of medical treatment of endometriosis: a systematic review
Becker, C. M., Gattrell, W. T., Gude, K., & Singh, S. S. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.05.004 · Cited by 302
A quantitative overview of controlled trials in endometriosis-associated infertility
Hughes, E. G., Fedorkow, D. M., & Collins, J. A. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55911-1 · Cited by 259
Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up
Waller, K. G., & Shaw, R. W. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55791-4 · Cited by 249
Self-citation
Ovulation suppression for endometriosis
Hughes, E., Fedorkow, D. M., Collins, J. A., & Vandekerckhove, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000155 · Cited by 242
Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert-panel consensus process
Gambone, J. C., Mittman, B. S., Munro, M. G., Scialli, A. R., & Winkel, C. A. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)04216-4 · Cited by 181
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
Veth, V. B., van de Kar, M. M., McDonnell, R., Julania, S., & Hart, R. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008475.pub2 · Cited by 182
Surgical and medical treatment of adenomyosis
Wood, C. (1998) · Human Reproduction Update · doi:10.1093/humupd/4.4.323 · Cited by 180
Tumor Necrosis Factor-α-Induced Interleukin-8 (IL-8) Expression in Endometriotic Stromal Cells, Probably through Nuclear Factor-κB Activation: Gonadotropin-Releasing Hormone Agonist Treatment Reduced IL-8 Expression
Sakamoto, Y., Harada, T., Horie, S., Iba, Y., Taniguchi, F., Yoshida, S., Iwabe, T., & Terakawa, N. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020666 · Cited by 153
Medical management of endometriosis and infertility
Lessey, B. A. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00519-7 · Cited by 158
In vitro fertilization is a successful treatment in endometriosis-associated infertility
Opøien, H. K., Fedorcsák, P., Omland, A. K., Åbyholm, T., Bjercke, S., Ertzeid, G., Oldereid, N. B., Mellembakken, J. R., & Tanbo, T. G. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.01.112 · Cited by 158
Endometriosis: Treatment Strategies
VALLE, R. F., & Sciarra, J. J. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.026 · Cited by 151
Adolescent Endometriosis
Laufer, M. R., Sanfilippo, J., & Rose, G. (2003) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/s1083-3188(03)00066-4 · Cited by 143
Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials: report from the Art and Science of Endometriosis meeting
Vincent, K., Kennedy, S., & Stratton, P. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.056 · Cited by 132
Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain
Hornstein, M. D., Yuzpe, A. A., Burry, K. A., Heinrichs, L. R., Buttram, V. C., & ORWOLL, E. S. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57530-x · Cited by 125
Ovulation suppression for endometriosis for women with subfertility
Hughes, E., Brown, J., Collins, J. J., Farquhar, C., Fedorkow, D. M., & Vanderkerchove, P. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000155.pub2 · Cited by 121
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
Prentice, A., Deary, A., Goldbeck-Wood, S., Farquhar, C., & Smith, S. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000346 · Cited by 116
Retracted
The mTOR/AKT Inhibitor Temsirolimus Prevents Deep Infiltrating Endometriosis in Mice
Leconte, M., Nicco, C., Ngô, C., Chéreau, C., Chouzenoux, S., Marut, W., Guibourdenche, J., Arkwright, S., Weill, B. J., Chapron, C., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.020 · Cited by 117
The Treatment of Endometriosis
Olive, D. L., & Pritts, E. A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02797.x · Cited by 95
The evidence for the management of endometriosis
Farquhar, C. M., & Suttonb, C. (1998) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-199808000-00007 · Cited by 87
The Physiology and Pathology of the Female Reproductive Axis
Bulun, S. E., Adashi, E. Y., & Bulun, S. E. (2007) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50018-2 · Cited by 84
Treatment of endometriosis
Shaw, R. W. (1992) · The Lancet · doi:10.1016/0140-6736(92)92960-n · Cited by 85
Self-citation
An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells
Izawa, M., Harada, T., Taniguchi, F., Ohama, Y., Takenaka, Y., & Terakawa, N. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.03.078 · Cited by 83
The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl)
Lindsay, P., Shaw, R. W., Bennink, H. J. T. C., & Pm, K. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58096-0 · Cited by 81
Self-citation
Gonadotropin-releasing hormone agonist treatment for endometriosis of the rectovaginal septum
Fedele, L., Bianchi, S., Zanconato, G., Tozzi, L., & Raffaelli, R. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.108021 · Cited by 79
Emerging drugs for endometriosis
Fedele, L., & Berlanda, N. (2004) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.9.1.167 · Cited by 73
Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis
Kiilholma, P., Tuimala, R. J., Kivinen, S., Korhonen, M., & Hagman, E. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57900-x · Cited by 71
Medical management of endometriosis-associated pain
Mahutte, N. G., & Arici, A. (2003) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(02)00057-8 · Cited by 68
Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone “add-back” therapy
Surrey, E. S., Voigt, B., Fournet, N., & Judd, H. L. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57476-7 · Cited by 61
Gonadotrophin-Releasing Hormone Agonists
Filicori, M. (1994) · Drugs · doi:10.2165/00003495-199448010-00005 · Cited by 60
Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women
Craig, M., Fletcher, P. C., Daly, E., RYMER, J. M., Cutter, W. J., Brammer, M. J., Giampietro, V., Wickham, H., Maki, P. M., & Murphy, D. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.09.009 · Cited by 56
Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis
Regidor, P., Regidor, M., Schmidt, M., Ruwe, B., Lübben, G., Förtig, P., Kienle, E., & Schindler, A. E. (2001) · Gynecological Endocrinology · doi:10.1080/gye.15.3.202.209 · Cited by 56
Clinical Pharmacokinetics of Goserelin
Cockshott, I. D. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039010-00003 · Cited by 55
Medical and Surgical Therapies for Pain Associated with Endometriosis
Winkel, C. A., & Scialli, A. R. (2001) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/152460901300039485 · Cited by 54
European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia
Mansel, R. E., Goyal, A., PREECE, P. E., Leinster, S., Maddox, P. R., Gateley, C., Kubista, E., & von Fournier, D. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.06.100 · Cited by 54
High-dose pilot study with the novel progestogen dienogestin patients with endometriosis
Schindler, A. E., Christensen, B., Henkel, A., Oettel, M., & Moore, C. (2006) · Gynecological Endocrinology · doi:10.1080/09513590500431482 · Cited by 53
Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome
Mitwally, M. F. M., Gotlieb, L., & Casper, R. F. (2002) · Menopause · doi:10.1097/00042192-200207000-00004 · Cited by 53
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
Prentice, A., Deary, A. J., Goldbeck-Wood, S., Farquhar, C. M., & Smith, S. K. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000346.pub2 · Cited by 49
A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis
Cirkel, U., Ochs, H., & Schneider, H. P. G. (1995) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(94)02016-8 · Cited by 50
Epigenetic aberration of gene expression in endometriosis
Izawa, M. (2013) · Frontiers in Bioscience · doi:10.2741/e669 · Cited by 49
DYSMENORRHEA AND PELVIC PAIN IN ADOLESCENTS
Schroeder, B. A., & Sanfilippo, J. S. (1999) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70137-1 · Cited by 49
Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas
Iwabe, T., Harada, T., Sakamoto, Y., Iba, Y., Horie, S., Mitsunari, M., & Terakawa, N. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00609-5 · Cited by 48
Gonadotropin-releasing hormone agonist plus estrogen-progestin “add-back” therapy for endometriosis-related pelvic pain
Friedman, A. J., & Hornstein, M. D. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56090-7 · Cited by 47
Retracted
Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials
Samy, A., Taher, A. M., Sileem, S., Abdelhakim, A. M., Fathi, M. M., Haggag, H. M., Ashour, K., Ahmed, S. A., Shareef, M. A., AlAmodi, A. A., et al. (2020) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2020.101798 · Cited by 44
Goserelin
Perry, C. M., & Brogden, R. N. (1996) · Drugs · doi:10.2165/00003495-199651020-00009 · Cited by 43
Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin- releasing hormone agonist
Miller, J. D., Shaw, R. W., Casper, R. F., Rock, J. A., Thomas, E. J., Dmowski, W. P., Surrey, E. S., Malinak, L. R., & Moghissi, K. S. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00166-6 · Cited by 43
Self-citation
GnRH analogs: Options for endometriosis-associated pain treatment
Batzer, F. R. (2006) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2006.07.007 · Cited by 42
Endometriosis, 1995 - confusion or sense?
Thomas, E. (1995) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(94)02277-6 · Cited by 42
GnRH agonists in the treatment of symptomatic endometriosis: a review
Surrey, E. S. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.11.009 · Cited by 46
Physiology and Pathology of the Female Reproductive Axis
Bulun, S. E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00017-1 · Cited by 40
9 Endometriosis: Medical therapy
Wingfield, M. B., & Healy, D. L. (1993) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(05)80465-1 · Cited by 39
Gonadotropin-releasing hormone analogues for endometriosis
Veth, V. B., van de Kar, M. M., Duffy, J. M., van Wely, M., Mijatovic, V., & Maas, J. W. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014788.pub2 · Cited by 39
Management of the Pain Associated with Endometriosis: An Update of the Painful Problems
Ozawa, Y., Murakami, T., Terada, Y., Yaegashi, N., Okamura, K., Kuriyama, S., & Tsuji, I. (2006) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.210.175 · Cited by 38
Sertraline in the Treatment of Depression Associated with Gonadotropin-Releasing Hormone Agonist Therapy
Warnock, J. K., Bundren, J. C., & Morris, D. W. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00396-x · Cited by 38
Optimizing Gonadotropin-Releasing Hormone Agonist Therapy in Women with Endometriosis
Olive, D. L. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403020-00003 · Cited by 38
MODERN MEDICAL MANAGEMENT OF ENDOMETRIOSIS
Kettel, L. M., & Hummel, W. P. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70309-0 · Cited by 38
Endometriosis: An Overview of the Disease and Its Treatment
Frackiewicz, E. J. (2000) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31105-6 · Cited by 37
Voice changes in women treated for endometriosis and related conditions: The need for comprehensive vocal assessment
Pattie, M. A., Murdoch, B. E., Theodoros, D., & Forbes, K. L. (1998) · Journal of Voice · doi:10.1016/s0892-1997(98)80027-1 · Cited by 35
Changing concepts of medical treatment of endometriosis
Kauppila, A. (1993) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349309021107 · Cited by 31
Pain recurrence: A quality of life issue in endometriosis
Damario, M. A., & Rock, J. A. (1995) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(95)02512-b · Cited by 27
Adhesion formation and reformation after laparoscopic removal of ovarian endometriomas
Gürgan, T., Urman, B., & Yaralı́, H. (1996) · The Journal of the American Association of Gynecologic Laparoscopists · doi:10.1016/s1074-3804(96)80069-7 · Cited by 26
Development and Validation of the Endometriosis Daily Pain Impact Diary Items to Assess Dysmenorrhea and Nonmenstrual Pelvic Pain
Wyrwich, K. W., O’Brien, C. F., Soliman, A. M., & Chwalisż, K. (2018) · Reproductive Sciences · doi:10.1177/1933719118789509 · Cited by 24
Endometriosis: still an enigma
Thomas, E. J. (1993) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1993.tb14225.x · Cited by 23
Physiology and Pathology of the Female Reproductive Axis
Bulun, S. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00017-4 · Cited by 22
Today's treatments: medical, surgical and in partnership
Donnez, J. (1999) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(98)00236-7 · Cited by 19
Long-term Gonadotropin-releasing Hormone Agonist Therapy:The Evolving Issue of Steroidal "Add-back" Paradigms.
Adashi, E. Y. (1995) · The Keio Journal of Medicine · doi:10.2302/kjm.44.124 · Cited by 19
Long-acting triptorelin for the treatment of endometriosis
Choktanasiri, W., Boonkasemsanti, W., Sittisomwong, T., Kunathikom, S., Suksompong, S., Udomsubpayakul, U., & Rojanasakul, A. (1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)02698-7 · Cited by 18
Effect on insulin sensitivity of Implanon vs. GnRH agonist in women with endometriosis
Cagnacci, A., Tirelli, A., Cannoletta, M., Pirillo, D., & Volpe, A. (2005) · Contraception · doi:10.1016/j.contraception.2005.05.021 · Cited by 17
The efficacy of drugs in the management of endometriosis
Bulletti, C., Flamigni, C., POLLI, V., Giacomucci, E., Albonetti, A., Negrini, V., Galassi, A., & Morselli‐Labate, A. M. (1996) · The Journal of the American Association of Gynecologic Laparoscopists · doi:10.1016/s1074-3804(05)80157-4 · Cited by 18
Deeply Infiltrating Endometriosis: Implications, Diagnosis, and Management
Kwok, A., Lam, A. M., & Ford, R. M. (2001) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200103000-00024 · Cited by 18
“Per vaginam” topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review
Buggio, L., Lazzari, C., Monti, E., Barbàra, G., Berlanda, N., & Vercellini, P. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4448-z · Cited by 17
A Risk Benefit Assessment of Drugs Used in the Treatment of Endometriosis
Shaw, R. W. (1994) · Drug Safety · doi:10.2165/00002018-199411020-00005 · Cited by 16
Self-citation
Systemic Hypersensitivity Reaction to Goserelin Acetate
Raj, S. G., Karadsheh, A. J., Guillot, R. J., Raj, M. H. G., & Kumar, P. (1996) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)41803-8 · Cited by 15
Goserelin Depot Versus Danazol in the Treatment of Endometriosis The Australian/New Zealand Experience*
(1996) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1996.tb02924.x · Cited by 15
Evaluation of the Role of Laser Treatment for the Treatment of Pain in Endometriosis
Shaw, R. W. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.027 · Cited by 15
Self-citation
Medical treatment of symptomatic endometriosis
Cirkel, U. (1996) · Human Reproduction · doi:10.1093/humrep/11.suppl_3.89 · Cited by 15
Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata
Miller, J. D., & Anderson, M. G. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00055-0 · Cited by 13
A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action
Rosenberger, D. C., Mennicken, E., Schmieg, I., Medkour, T., Péchard, M., Sachau, J., Fuchtmann, F., Birch, J. V., Schnabel, K., Vincent, K., et al. (2024) · Pain · doi:10.1097/j.pain.0000000000003290 · Cited by 13
Combined Medical and Surgical Treatment of Women with Endometriosis
Winkel, C. A. (1999) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-199909000-00018 · Cited by 10
Goserelin (Zoladex) versus danazol for endometriosis: the North American experience
Damario, M. A., & Rock, J. A. (1994) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1994.tb13679.x · Cited by 8
Health and fertility outcomes among women surgically treated for endometriosis
Batt, R. E., Louis, G. M. B., & Smith, R. A. (1997) · The Journal of the American Association of Gynecologic Laparoscopists · doi:10.1016/s1074-3804(05)80035-0 · Cited by 8
Treatment of dysfunctional uterine bleeding in the perimenopause: The effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment – a randomized, placebo-controlled, double-blind trial
Franke, H. R., Snaaijer, F. F., Houben, P. W. H., & van der Mooren, M. J. (2006) · Gynecological Endocrinology · doi:10.1080/09513590601015101 · Cited by 7
Today's treatments: how do you choose?
Barlow, D. (1999) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(98)00237-9 · Cited by 7
Danazol
Al‐Badr, A. A. (2022) · Profiles of drug substances, excipients, and related methodology · doi:10.1016/bs.podrm.2021.10.005 · Cited by 6
Combined use of a long-acting gonadotropin-releasing hormone agonist and low-dose danazol in advanced stage endometriosis
Uğur, M., Şenöz, S., & Gökmen, O. (1996) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0301-2115(96)02499-2 · Cited by 5
The Role of Medical Management in the Treatment of Endometriosis
Dmowski, W. P. (1995) · Springer eBooks · doi:10.1007/978-1-4613-8404-5_23 · Cited by 5
Endometriosis
Lobo, R. A. (2007) · Comprehensive Gynecology · doi:10.1016/b978-0-323-02951-3.50022-4 · Cited by 4
Epigenetics in Endometriosis
Izawa, M., Taniguchi, F., & Harada, T. (2014) · Springer eBooks · doi:10.1007/978-4-431-54421-0_8 · Cited by 4
Endometriosis
Advincula, A. P., Truong, M., & Lobo, R. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-65399-2.00028-0 · Cited by 3
Medical Therapy for Endometriosis
Surrey, E. S. (2003) · CRC Press eBooks · doi:10.1201/b14235-11 · Cited by 3
Mastalgia
Goyal, A., & Mansel, R. E. (2010) · Springer eBooks · doi:10.1007/978-3-540-69743-5_4 · Cited by 3
The success of laser laparoscopy in the treatment of endometriosis: a two-step analysis.
Paulson, J. D., Borremeo, R., & Speck, G. (2001) · PubMed Central · Cited by 3
Comparison between medical treatment by GnRH analogue (goserelin) and conservative surgery by laparoscopic diathermy for the management of endometriosis
Hefni, M. A., Apoola, A., & Omran (1998) · Gynaecological Endoscopy · doi:10.1046/j.1365-2508.1998.00154.x · Cited by 3
Tratamiento de la endometriosis y medicina basada en la evidencia
Balasch, J. (2003) · Progresos de Obstetricia y Ginecología · doi:10.1016/s0304-5013(03)75853-1 · Cited by 2
Endometriosis: critical assessment of current therapies
Buckett, W. M., Saleh, A., Tulandi, T., & Tan, S. L. (1998) · Current Obstetrics and Gynaecology · doi:10.1016/s0957-5847(98)80048-6 · Cited by 2
Medical Management of Endometriosis
Fedele, L., Bianchi, S., Fontana, E., Berlanda, N., Frontino, G., & Bulfoni, A. (2006) · Women s Health · doi:10.2217/17455057.2.2.297 · Cited by 1
Endometriosis
Lahoud, R., & Harrison, R. F. (2003) · CRC Press eBooks · doi:10.1201/b14235-13 · Cited by 1
Infertility
Runnebaum, B., Rabe, T., Sillem, M., & Eggert-Kruse, W. (1997) · Springer eBooks · doi:10.1007/978-3-642-60390-7_20 · Cited by 1
Sterilität
Runnebaum, B., Rabe, T., Sillem, M., & Eggert-Kruse, W. (1994) · Springer eBooks · doi:10.1007/978-3-662-07633-0_4 · Cited by 1

Authors: Shaw, R. W.
Affiliations: The Royal Free Hospital (GB)
Corresponding author: Shaw, Robert W.
Venue: Fertility and Sterility
Publisher: Elsevier BV
Published: 1992-08
Volume: 58
Issue: 2
Pages: 265-272
ISSN: 0015-0282 (ISSN-L)
DOI: 10.1016/s0015-0282(16)55205-4
OpenAlex: W2417044776
Cited by: 119
References: 18
Citations by year: 2026: 3 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2014: 1 · 2013: 1 · 2012: 2
FWCI: 8.13
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 10891 d)
Locations: Fertility and Sterility (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords: endometriosis, danazol, GnRH agonist therapy, symptom scores, treatment efficacy, treatment safety, androgenic side effects, weight gain, infertility
MeSH terms: Adolescent, Adult, Buserelin, Danazol, Delayed-Action Preparations, Endometriosis, Female, Humans, Menstruation, Pregnancy, Goserelin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks